Jeroen B. van Beek - 02 Mar 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
02 Mar 2022
Net transactions value
-$4,651
Form type
4
Filing time
03 Mar 2022, 15:15:47 UTC
Previous filing
18 Feb 2022
Next filing
22 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $4,651 -516 -0.13% $9.01 382,384 02 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.01 to $9.015. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.